Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.61 |
| ▸ | DRD2 | P14416 | 1/20 | 0.58 |
| ▸ | DRD1 | P21728 | 1/20 | 0.58 |
| ▸ | DRD3 | P35462 | 1/20 | 0.58 |
| ▸ | TSHR | P16473 | 1/20 | 0.51 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.51 |
| ▸ | BCHE | P06276 | 5/20 | 0.51 |
| ▸ | ACHE | P22303 | 2/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | LTA4H | P09960 | 1/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.50 |
| ▸ | MAOB | P27338 | 1/20 | 0.49 |
| ▸ | HTR1A | P08908 | 1/20 | 0.49 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.49 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.49 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Guaiactamine SCHEMBL25797 | 0.87 | ALDH1A1 (0.78) | ALDH1A1DRD2DRD1DRD3BCHE | |
| SCHEMBL7128494 | 0.82 | ALDH1A1 (0.55) | ALDH1A1DRD2DRD1DRD3BCHE | |
| SCHEMBL615299 | 0.80 | TSHR (0.56) | DRD2DRD1DRD3TSHRMAPK1 | |
| SCHEMBL2906267 | 0.80 | HTR1A (0.50) | ALDH1A1DRD2DRD1DRD3TSHR | |
| SCHEMBL9706154 | 0.80 | DRD3 (0.67) | ALDH1A1DRD2DRD1DRD3TSHR | |
| SCHEMBL7764563 | 0.79 | LMNA (0.58) | ALDH1A1BCHEACHEMAOBKDM4E | |
| SCHEMBL13916263 | 0.79 | POLB (0.49) | ALDH1A1DRD2DRD1DRD3TSHR | |
| Hydrochloric Acid SCHEMBL30961584 | 0.78 | ALDH1A1 (0.59) | ALDH1A1EBPTMEM97SIGMAR1 | |
| SCHEMBL8150113 | 0.77 | HCRTR2 (0.49) | ALDH1A1BCHEACHELTA4HLMNA | |
| SCHEMBL1966402 | 0.77 | L3MBTL1 (0.70) | ALDH1A1DRD2DRD1DRD3BCHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030181446-A1 | Novel N-acylated heterocycles | RECORDATI S.A. | 2003-09-25 | — | — | US | disclosed |
| US-20030162777-A1 | Novel N-acylated heterocycles | RECORDATI S.A. | 2003-08-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030162777-A1 | Novel N-acylated heterocycles | HTR1A, HTR1D, HTR1E | ALDH1A1 1076/4885DRD2 163/4885DRD1 133/4885 |
| US-20030181446-A1 | Novel N-acylated heterocycles | HTR1A, HTR1E, HTR2C | ALDH1A1 595/4885DRD2 85/4885DRD1 54/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.